In our study, we used LNCaP and LNCaP-C81 cells to study the role of dioscin in PCa; we artificially reduced the uncontrollable endogenous or exocrine IL-6 expression levels from tumor cells that interfered with the results of this study. The gene discussed is IL6; the disease is posterior cortical atrophy.